Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple sclerosis: Pregnancy, fertility, and assisted reproductive technology-a review.
Oreja-Guevara C, Gónzalez-Suárez I, Bilbao MM, Gómez-Palomares JL, Rodríguez CH, Rabanal A, Benito YA. Oreja-Guevara C, et al. Among authors: gonzalez suarez i. Mult Scler Relat Disord. 2024 Dec;92:105893. doi: 10.1016/j.msard.2024.105893. Epub 2024 Sep 21. Mult Scler Relat Disord. 2024. PMID: 39393162 Free article. Review.
Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis.
Canto-Gomes J, Boleixa D, Teixeira C, Martins da Silva A, González-Suárez I, Cerqueira J, Correia-Neves M, Nobrega C. Canto-Gomes J, et al. Among authors: gonzalez suarez i. Int Immunopharmacol. 2024 Apr 20;131:111826. doi: 10.1016/j.intimp.2024.111826. Epub 2024 Mar 10. Int Immunopharmacol. 2024. PMID: 38461632 Free article.
Corrigendum to "Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis" [Int. Immunopharmacol. 131 (2024) 111826].
Canto-Gomes J, Boleixa D, Teixeira C, da Silva AM, González-Suárez I, Cerqueira J, Correia-Neves M, Nobrega C. Canto-Gomes J, et al. Among authors: gonzalez suarez i. Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113555. doi: 10.1016/j.intimp.2024.113555. Epub 2024 Nov 4. Int Immunopharmacol. 2024. PMID: 39500664 Free article. No abstract available.
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Villacieros-Álvarez J, Espejo C, Arrambide G, Dinoto A, Mulero P, Rubio-Flores L, Nieto P, Alcalá C, Meca-Lallana JE, Millan-Pascual J, Martínez-García P, Bernard-Valnet R, González-Suárez I, Orviz A, Téllez R, Navarro Cantó L, Presas-Rodríguez S, Martínez-Yélamos S, Cuello JP, Alonso A, Piñar Morales R, Álvarez Bravo G, Benyahya L, Trouillet-Assant S, Dyon-Tafan V, Froment Tilikete C, Ruet A, Bourre B, Deschamps R, Papeix C, Maillart E, Kerschen P, Ayrignac X, Rovira À, Auger C, Audoin B, Montalban X, Tintore M, Mariotto S, Cobo-Calvo A, Marignier R. Villacieros-Álvarez J, et al. Among authors: gonzalez suarez i. Neurol Neuroimmunol Neuroinflamm. 2025 Mar;12(2):e200362. doi: 10.1212/NXI.0000000000200362. Epub 2025 Jan 3. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39752619 Free PMC article.
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside Attacks.
Fonseca E, Olivé-Cirera G, Martinez-Hernandez E, Guasp M, Naranjo L, Ruiz-García R, Caballero E, González-Álvarez V, Delgadillo V, Romeu G, Del-Prado-Sánchez C, Cabrera-Maqueda JM, Benito-León J, Iñiguez C, Garcia-Dominguez JM, Calles C, Cano A, Álvarez-Bravo G, González-Suárez I, Oreja-Guevara C, Ros M, Millan-Pascual J, Meca-Lallana JE, Borrega Canelo L, Martín-Martínez J, Palao M, Gracia J, Villaverde-González R, Llufriu S, Blanco Y, Saiz A, Dalmau J, Sepulveda M, Armangue T; Spanish MOGAD study group. Fonseca E, et al. Among authors: gonzalez suarez i. Neurology. 2024 Sep 24;103(6):e209682. doi: 10.1212/WNL.0000000000209682. Epub 2024 Aug 27. Neurology. 2024. PMID: 39190859
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.
Sancho-Saldaña A, Gil-Sánchez A, González-Mingot C, Peralta S, Solana MJ, Torres P, Juanes A, Quibus L, Ruiz E, Sanpedro E, Quirant-Sánchez B, Martínez-Cáceres E, Ramo Tello C, Presas-Rodríguez S, García Rubio S, Baron BP, Ramió-Torrentà L, Sotoca J, González-Suárez I, Eichau S, Prieto-González JM, Blasco Quilez MR, Sabín-Muñoz J, Sánchez-López AJ, Llorens Calatayud G, Calles C, Sempere ÁP, Garcés M, Carmona O, Moral E, Hervás JV, Blanco Y, Sola-Valls N, Tellez Lara N, Forero L, Brieva L. Sancho-Saldaña A, et al. Among authors: gonzalez suarez i. J Clin Med. 2023 Nov 23;12(23):7243. doi: 10.3390/jcm12237243. J Clin Med. 2023. PMID: 38068295 Free PMC article.
Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response.
Domínguez-Mozo MI, González-Suárez I, Villar LM, Costa-Frossard L, Villarrubia N, Aladro Y, Pilo B, Montalbán X, Comabella M, Casanova-Peño I, Martínez-Ginés ML, García-Domínguez JM, García-Martínez MÁ, Arroyo R, Álvarez-Lafuente R. Domínguez-Mozo MI, et al. Among authors: gonzalez suarez i. Front Immunol. 2023 Sep 29;14:1248182. doi: 10.3389/fimmu.2023.1248182. eCollection 2023. Front Immunol. 2023. PMID: 37841253 Free PMC article.
Real-world persistence to first-line DMTs in relapsing-remitting multiple sclerosis.
López-Caneda C, Pérez-Haro MJ, Sánchez-Franco C, Álvarez-Rodríguez E, Aguado-Valcárcel M, Marcos-Bobillo M, González-Suarez I. López-Caneda C, et al. Among authors: gonzalez suarez i. Mult Scler Relat Disord. 2023 Oct;78:104909. doi: 10.1016/j.msard.2023.104909. Epub 2023 Jul 22. Mult Scler Relat Disord. 2023. PMID: 37603928
64 results